posted
Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations Thursday October 4, 8:30 am ET
MAUI, Hawaii, Oct. 4 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has retained OTC Financial Network, a division of National Financial Communications Corporation, as its investor relations representative.
Sales of CAM reached $5 billion in 2005, and approximately 62% of U.S. adults are using some form of CAM for preventing and managing chronic disease, according to Med Ad News. Geoffrey Eiten, president of National Financial Communications, commented, "Bioponic has developed a patented, new natural healing modality and an extensive suite of branded product lines that serve explosive growth in alternative medicine."
Eiten says, "Several independent research studies suggest turmeric, a key ingredient in Bioponic's Curecurmin(TM) product can provide efficacious and natural treatment to some of the world's most prevalent, incurable diseases." Independent research studies on the anti-cancer properties of turmeric suggests that curcumin has the potential for treatment of five top cancers in the U.S. -- colon, breast, prostate, lung and skin. Additionally, UCLA/VA researchers found that curcumin -- a chemical found in curry and turmeric -- may help the immune system clear the brain of amyloid beta, which forms the plaques found in Alzheimer's disease. See the press release at http://www.j-alz.com/press/2006/20061003.html.
"This is a truly an exciting revelation in Bioponic's history, and we think investors will be interested in following this company closely. We look forward to representing Bioponic to the financial community and helping it to achieve greater market exposure," added Eiten.
Steven M. Schorr, Chairman & CEO of Bioponic, said, "We have retained OTC Financial Network to help us enhance our shareholder communications and attract new investors as we capitalize on the immense growth opportunities in CAM and natural consumer products."
About OTC Financial Network
OTC Financial Network (OTCFN) has carved its niche as the nation's leading small/micro-cap investor relations and financial communications firm. OTCFN provides full-service investor relations, consulting services and customized marketing campaigns designed to maximize investor awareness for small/ micro-cap publicly traded companies. Since its inception in 1992, OTCFN has represented over 500 clients. To view a current client list or for more information, visit http://www.otcfn.com. OTCFN is a division of National Financial Communications Corp. (http://www.nationalfc.com) based in Needham, MA.
Disclaimer: OTC Financial Network (OTCFN) serves as special advisor to the featured Company and has received fees for services, including a monthly retainer of five thousand dollars, plus an option to purchase an aggregate of one million five hundred thousand shares at an exercise price of ten cents per share, plus expenses, for the creation and distribution of materials. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Additional compensation information and a full disclaimer can be found online by visiting http://www.otcfn.com/bpyt/disclaimer.html.
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com) and the skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being. For more information, visit http://www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, geiten*otcfn.com, www.otcfn.com/bpyt.
-------------------------------------------------------------------------------- Source: Bioponic Phytoceuticals, Inc.
IP: Logged |
posted
Last time I post, I forgot to mention about one interesting product that Bioponic has which is FLIGHT SPRAY, the first nasal hydration spray for airlines travelers. It was on ABC GOOD MORNING AMERICA. This product is similar with Airborne but you need to spray it to your nose so I think your body will absorb it faster. Here is their website:
posted
Volume start to pick up, it’s up 23.53% this morning and Bioponic just add NONI HEALING TONIC to its product lines. It is an oral spray that balances the bodies normal operating functions and promotes health and well being. Take a look at the website for more info:
posted
This stock is waking up strong, I guess something will happen and somebody knows that for sure, going up with nice volume should be a good sign.
IP: Logged |
posted
Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States Tuesday October 16, 8:30 am ET
MAUI, Hawaii, Oct. 16 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (OTC: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it has engaged Active Sales and Marketing of Southern California as its Master Distributor covering the Western United States, including the states of California, Washington, Nevada, Arizona, Colorado, Utah, Idaho, New Mexico and Oregon.
The agreement will initially distribute six of Bioponic's most popular health and well-being products: Hawaiian Healing Mist(TM); O-Spray(TM); Throat Note(TM); Traveler's 1st Aid(TM); Noni Healing Tonic and Ginzeng! Descriptions of these products can be found at http://www.bioponic.com.
According to the Natural Foods Merchandiser, in 2006, retail channels accounted for 81%, or $46.1 billion, of total natural product sales in the U.S. Steven M. Schorr, Chairman & CEO of Bioponic, said, "With this agreement, we mark a significant new milestone in carving out an all-important U.S. retail presence beyond the local Hawaiian market."
Schorr continued, "Some of today's largest retail chains and supermarkets were founded on natural and organic product lines. Active Sales and Marketing brings established channels with the pioneers and leaders in the natural/nutraceutical market, and provides a direct path to favorable shelf space within highly trafficked major retailers. Based on our ability to bring six products to about 1,000 stores throughout 2008, we believe we can successfully generate additional sales of $1.5 million or more by the end of next year."
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com), O-Spray(TM), Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being. For more information, visit www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, geiten*otcfn.com, www.otcfn.com/bpyt.
-------------------------------------------------------------------------------- Source: Bioponic Phytoceuticals, Inc.
IP: Logged |
posted
Bioponic Phytoceuticals Receives Initial Order From Singapore Distributor to Launch Asia-Pacific Retail Sales Wednesday October 24, 8:40 am ET
MAUI, Hawaii, Oct. 24 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (OTC: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today that it received an initial order from Muji Global Sourcing Pte. Ltd. ("Muji"), a natural products retail distributor based in Singapore. Muji will distribute several Bioponic product lines, including Flight Spray(TM), Hawaiian Healing Mist(TM), Auntie Mahi Poe Poe's Healing Tonics, Noni Healing Tonic(TM) and the Noni Care collection, to reach billions of people in the Asia-Pacific region. Muji will market Bioponic products primarily in Japan, China, Malaysia, Thailand, Taiwan and Vietnam.
President of Bioponic Phytoceuticals, Steven Schorr, said, "Our Singapore distributor is expertly timed to capitalize on emerging health trends taking over Asia. Our Noni Healing Tonic is based on the Pacific noni-fruit, which has treated various diseases for hundreds of years in Hawaii, the Pacific Islands and Southeast Asia. Noni is now a much sought after ingredient throughout all regions of Asia. Medicinal uses, contemporary and worldwide, value the power of noni for the treatment of dozens of ailments from attention deficit disorder, addictions, allergies, arthritis and asthma to cardiovascular disease and digestive problems. Our Noni Healing Tonic could potentially be the catalyst that drives our Asian sales presence."
Schorr concluded, "In addition to consumer retail, Muji has experience in selling to commercial international markets, such as the airline and travel industry, which will help us establish market share for anti-infectious products like Flight Spray beginning in 2008."
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com), O-Spray(TM), Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well being. For more information, visit http://www.bioponic.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, +1-781-444-6100x613, geiten*otcfn.com, http://www.otcfn.com/bpyt.
posted
Bioponic Phytoceuticals Plans to Bring Flight Spray Product to Mass Market Retailers Nationwide Beginning in Q1 2008 Thursday November 1, 8:49 am ET
MAUI, Hawaii, Nov. 1 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that it is preparing to launch a national roll-out of its nasal hydration product Flight Spray® to mass market retailers and top-name pharmacy and drug store chains beginning in the first quarter of 2008.
Flight Spray has sold over 50,000 units since its initial launch in April 2005. "We are preparing for a mass market push that has the potential to exponentially increase sales of Flight Spray during 2008," said Steven M. Schorr, chairman & CEO of Bioponic. "The early buzz on Flight Spray was that it was the next Airborne. Good Morning America and ABC Health News were among the first national media outlets to favorably compare it to Airborne. Considering Airborne sold over $100 million last year, Flight Spray could achieve similar sales success given the expansion we have planned in significantly large retail markets."
Flight Spray is currently sold in travel-related retail stores and via web sites such as Magellens.com, TravelSmith.com and Drugstore.com, and on the Company-owned FlightSpray.com. Flight Spray is also available on Amazon.com, along with 85 other Bioponic Phytoceuticals products, and at AllNaturalMerchandise.com. In Australia, Flight Spray is sold on GlobalTravelProducts.com and in the U.K. and Europe at Vocal-care.com. Flight Spray comes in a 1oz. (30ml) and .5oz (15ml) pump spray bottle and is now shelf ready in a display box.
Flight Spray is the first all-natural nasal hydration spray formulated especially for airline travel. The 1oz bottle of Flight spray is an approved on-board liquid, which eliminates consumer concerns over traveling regulations. The TSA web site says "exempted products may include the admission of up to 4 oz. of non-prescription medicine." Used to moisten the nasal passages and alleviate nasal dryness, Flight Spray helps prevent colds, flu and sore throats due to recycled airplane air and close proximity to those with transmittable symptoms. Formulated by combining two of the most effective herbal ingredients (Turmeric root and Spearmint), it provides an unsuitable environment for germs and viruses to reproduce.
"Flight Spray is a beneficial non-prescription remedy for millions of prospective airline travelers. Our customers rely on Flight Spray to keep them hydrated and healthy during long flights and we are pleased it will soon be available nationwide," added Schorr.
Bioponic Phytoceuticals is engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics(TM)" and has several branded product lines currently in national distribution. For further information please see www.bioponic.com and www.flightspray.com.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, +1-781-444-6100x613, geiten*otcfn.com, http://www.otcfn.com/bpyt.
-------------------------------------------------------------------------------- Source: Bioponic Phytoceuticals, Inc.
IP: Logged |
posted
Bioponic Phytoceuticals Launches Curemisinin for the Treatment of Malaria in Guinea, Africa Tuesday November 13, 8:30 am ET
MAUI, Hawaii, Nov. 13 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced today the launch of Curemisinin(TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs: Artemesia, Turmeric and Cinchona Bark, uniquely extracted through the Company's proprietary extraction/distillation technologies. This binary product comprises a nasal spray (Curemisinin A) with an oral spray (Curemisinin B) to treat malaria in the quickest, most effective manner.
Malaria is a disease caused by a blood parasite transmitted by mosquitoes, and the number one killer in sub-Saharan Africa, killing more than a million people worldwide, every year. The majority of those who die from malaria are African children, according to the Centers for Disease Control. Through Bioponic's international alliance with Hyperdynamics Corp, Curemisinin is currently being disseminated free-of-charge in clinics located in the capital city of Guinea, Africa. The efficacy of Bioponic's Curemisinin will be recorded, and provide valuable data over the next several weeks on the product's ability to treat malaria in humans.
Bioponic's Chairman and CEO Steven M. Schorr remarked, "Curemisinin's use of a nasal delivery system allows the bioresonant liquid remedy to be delivered directly to the brain via the nasal membrane. This may have a significant impact on Cerebral Malaria, a condition primarily affecting children, who die within 24 to 72 hours without treatment. Bioponic not only hopes to stop the track of cerebral malaria, but potentially help bring down the cost of treatment and increase the efficacy of treatments for all types of malaria, especially resistant strains of the disease."
As evolving pathogens develop widespread resistance to over-prescribed antibiotics, antivirals and antimalarial drugs, the use of natural medicines is being recommended for their proven efficacy, even by the World Health Organization, who has indicated the benefits of artemisinin-based combination therapies (ACTs) as the front line of treatment for the vast malaria problem. For more information on Bioponic and Curemisinin, visit http://www.bioponic.com.
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com); Curecumin(TM) (a treatment for Alzheimer's Disease); O-Spray(TM) (scented nasal sprays); Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the effective natural skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well-being.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, 781-444-6100x613, geiten*otcfn.com, http://www.otcfn.com/bpyt.
-------------------------------------------------------------------------------- Source: Bioponic Phytoceuticals, Inc.
IP: Logged |
posted
It was up 52.94% on Friday and there is news today:
Bioponic Phytoceuticals Introduces All Natural Baby Product Suite 'Gentle Mother' Monday November 19, 8:30 am ET
MAUI, Hawaii, Nov. 19 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. (Pink Sheets: BPYT - News; "Bioponic"), an innovative provider of natural products and patented technology serving the Complementary Alternative Medicine (CAM) and nutraceutical markets, announced the launch of its first product suite geared specifically for newborns and infants called "Gentle Mother(TM)". Gentle Mother is comprised of five, all natural herbal remedies based on the Company's proprietary Bioresonant Phytotherapeutic(TM) formulations with easy-to-use, liquid spray delivery systems. Each product is a gentle water-based formula designed to soothe and treat common, recurring ailments such as diaper rash, teething, nasal congestion, as well as aide in digestion and sleep.
"Many parents are turning towards all natural baby formulations to avoid additives and unwanted preservatives that may cause side effects or can be detrimental to their children's health, especially over extended periods of use. Consumers are more health conscious, environmentally aware and receptive to alternative remedies than ever before. Demand for natural baby products is dramatically on the rise, and a number of the world's leading brands and grocers are clearing shelf space for 'green' baby product lines. For instance, one leading food chain has tripled the space allotted to natural baby products in just the last five years," said Steven M. Schorr, chairman and CEO of Bioponic.
Gentle Mother is currently available for purchase at http://www.bioponic.com and will soon be available in leading health food stores. According to Schorr, "We are very enthusiastic to begin marketing Gentle Mother worldwide, and in early 2008 we plan to make the entire suite available in over 1,000 health food stores. We have the distribution agreements in place to take several of our products to a national scale, and Gentle Mother is a very promising addition in our product line-up for 2008."
Gentle Mother is made without additives, preservatives, artificial colors or other unnecessary ingredients typically found in mass-produced children's health formulas. All ingredients are safe and effective to use on newborns and infants, but as with all health products, it is recommended to check with your doctor prior to use.
About Bioponic Phytoceuticals
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic(TM) products. The Company has developed several branded product lines, including the nasal spray: Flight Spray® (http://www.flightspray.com); Curecumin(TM) (a treatment for Alzheimer's Disease); Curemisinin(TM) (a treatment for malaria); O-Spray(TM) (scented nasal sprays); Throat Note(TM) (formulated for professional speakers and singers, great for everyone!) and the effective natural skincare product Hawaiian Healing Mist(TM). Bioponic is focused on the production of natural products that are used to promote health and well being.
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.
CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711,
info*bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
